DRUG FOR TREATMENT

Brand Owner (click to sort) Address Description
'BRETYLATE' BURROUGHS WELLCOME & CO. (U.S.A.) INC. 11 EAST 41ST STREET NEW YORK CITY NY DRUG FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS;
BETASERC Unimed, Inc. Somerville NJ DRUG FOR THE TREATMENT OF CIRCULATORY DISORDERS AND PERIPHERAL VASCULAR DISEASE, AND FOR IMPROVING MICROCIRCULATION;
BYKONOX BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH. KONSTANZ, GERMANY DRUG FOR THE TREATMENT OF ANXIETY AND TENSION, INSOMNIA, RESTLESSNESS, CONVULSIVE DISORDERS, AND SEDATIVE AFTER OPERATIONS;
NEOCYLONE CENTRAL PHARMACAL COMPANY, THE 120 E. 3RD. ST. SEYMOUR IN Drug for the Treatment of Acute Inflammatory Diseases;
RUSEDAL CEDONA HARMACEUTISCHE FABRIEK N.V. GONNETSTRAAT 5-7 HAARLEM Netherlands DRUG FOR THE TREATMENT OF GASTRIC AND DUODENAL AFFLICTIONS;
SERC Unimed, Inc. Somerville NJ Drug for the Treatment of Circulatory Disorders and Peripheral Vascular Disease;
ZYLOPRIM CASPER PHARMA 2 TOWER CENTER BOULEVARD, SUITE 1401 EAST BRUNSWICK NJ 08816 Drug for the Treatment of Gout, Lukemia and Related Conditions;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A novel azasugar derivative, and a drug containing the same as an active ingredient are disclosed. The drug is useful for treatment of keratinocyte-proliferative diseases.